Brief: Redcare Pharmacy Q4 Total Sales At EUR 531 Mln.

Redcare Pharmacy NV

10/01/2024 05:48

Jan 10 (Reuters) - Redcare Pharmacy NV  RDC.DE :
    * ANOTHER SUCCESSFUL FAST-GROWTH QUARTER FOR REDCARE
PHARMACY,
COMPLETING FULL YEAR 2023 AT THE VERY UPPER END OF ITS GUIDANCE.
    * Q4 TOTAL SALES EUR 531M, YEAR-OVER-YEAR GROWTH 62%,
EXCLUDING
MEDISERVICE 23%.
    * FULL YEAR TOTAL SALES EUR 1.8BN VERSUS. GUIDANCE OF EUR
1.7-1.8BN, A GROWTH OF 49%. EXCLUDING MEDISERVICE, GROWTH WAS
24%.
    * NON-RX SALES GREW 23% TO EUR 362M IN Q4 AND 25% TO EUR
1.3BN
DURING FULL YEAR 2023 (VERSUS. LATEST GUIDANCE OF 20-30% FOR
FULL YEAR 2023).
    * ACTIVE CUSTOMER BASE INCREASED BY 0.3M IN Q4 TO 10.8M,
YEAR OVER
YEAR UP 1.5M.
    * IN Q4, SALES IN DACH SEGMENT (GERMANY, AUSTRIA AND
SWITZERLAND)
INCREASED BY 69% TO EUR 440 MILLION (Q4 2022: EUR 261 MILLION)
    * REDCARE PHARMACY N.V. WILL RELEASE FULL ANNUAL REPORT FOR
FISCAL
YEAR 2023 ON 5 MARCH 2024

Source text for Eikon:  ID:nEQc2wrQ6a 
Further company coverage:  RDC.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))